Vascular endothelial growth factor and enhanced angiogenesis do not promote metastatic conversion of a newly established azoxymethane-induced colon cancer cell line
Authors:
- 14 March 2005
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 43 (2) , 65-74
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Defective processing of the transforming growth factor‐β1 in azoxymethane‐induced mouse colon tumorsMolecular Carcinogenesis, 2003
- Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and TherapyJournal of Clinical Oncology, 2002
- Lipofuscin: mechanisms of age-related accumulation and influence on cell function12 1Guest Editor: Rajindar S. Sohal 2This article is part of a series of reviews on “Oxidative Stress and Aging.” The full list of papers may be found on the homepage of the journal.Free Radical Biology and Medicine, 2002
- Aberrant transforming growth factor‐β signaling in azoxymethane‐induced mouse colon tumorsMolecular Carcinogenesis, 2001
- Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesisCarcinogenesis, 2000
- Expression of Vascular Endothelial Growth Factor Induces an Invasive Phenotype in Human Squamous Cell CarcinomasThe American Journal of Pathology, 2000
- Quantitative assessment of azoxymethane-inducedaberrant crypt foci in inbred miceExperimental and Molecular Pathology, 1999
- Role of Protein Kinase C Isoforms in Phorbol Ester-induced Vascular Endothelial Growth Factor Expression in Human Glioblastoma CellsJournal of Biological Chemistry, 1999
- Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibilityCancer Letters, 1998
- A genetic model for colorectal tumorigenesisCell, 1990